$7.21 Billion is the total value of C WorldWide Group Holding A/S's 171 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BKNG | Exit | BOOKING HLDGS INC | $0 | – | -50 | -100.0% | -0.00% | – |
JPM | Exit | JPMORGAN CHASE & CO | $0 | – | -6,427 | -100.0% | -0.01% | – |
PF | Exit | PINNACLE FOODS INC DEL | $0 | – | -17,200 | -100.0% | -0.01% | – |
FLKS | Exit | FLEX PHARMA INC | $0 | – | -213,205 | -100.0% | -0.02% | – |
TJX | Exit | TJX COS INC NEW | $0 | – | -14,945 | -100.0% | -0.02% | – |
AFAM | Exit | ALMOST FAMILY INC | $0 | – | -30,026 | -100.0% | -0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VISA INC | 37 | Q3 2023 | 15.5% |
THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
ICICI BK LTD | 37 | Q3 2023 | 2.1% |
CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
DEX INC | 37 | Q3 2023 | 0.5% |
BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
INSULET CORP | 37 | Q3 2023 | 0.3% |
CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-03 |
13F-HR | 2024-02-05 |
13F-HR | 2023-11-03 |
13F-HR | 2023-08-02 |
13F-HR | 2023-05-02 |
13F-HR | 2023-02-03 |
13F-HR | 2022-11-03 |
13F-HR | 2022-08-02 |
13F-HR | 2022-05-04 |
13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.